检索

Possibilities of treatment of patients with resistant arterial hypertension

Shugushev Z., Maximkin D., Ryumina A.

(Rus)

卷 18, 编号 1 (2021)

Specificity of the effect of double fractures of the rhythmogram on the daily variability of the sinus rhythm in patients with pulmonary and arterial hypertension

Sobolev A., Ryabykina G., Kozhemyakina E.

(Rus)

卷 16, 编号 3 (2019)

Clinical, functional and hemodynamic profile of patients with Eisenmenger syndrome in comparison with the group of idiopathic pulmonary hypertension, features of starting specific therapy choice

Gratsianskaya S., Valieva Z., Zorin A., Martynyuk T.

(Rus)

卷 13, 编号 3 (2016)

Features of cutaneous microcirculatory blood flow in patients with pulmonary hypertension of different etiology

Dolgova E., Fedorovich A., Martynyuk T., Rogoza A., Chazova I.

(Rus)

卷 11, 编号 4 (2014)

The development of a screening questionnaire to improve the early detection of pulmonary arterial hypertension

Valieva Z., Valeeva E., Glukhova S., Martynyuk T., Chazova I.

(Rus)

卷 14, 编号 4 (2017)

Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Parts II-V

Chazova I., Tyulyandin S., Vitsenia M., Poltavskaya M., Gilyarov M., Martynyuk T., Ovchinnikov A., Panchenko E., Fedotkina Y., Stenina M., Trophimova O., Ageev F.

(Rus)

卷 18, 编号 3 (2021)

Efficacy and safety of azilsartan medoxomil in various doses in patients with metabolic disorders

Perepech N., Chazova I., Zhernakova J.

(Rus)

卷 17, 编号 3 (2020)

Contrast-associated acute kidney injury in patients with arterial hypertension and stable coronary artery disease

Mironova O., Fomin V.

(Rus)

Possible combinations of antihypertensive drugs at treatment of arterial hypertension at patientswith metabolic syndrome

Mychka V., Chazova I., Mychka V., Chazova I.

Efficacy of amlodipin in treatment of arterial hypertension.

Prokhorovich E.

卷 15, 编号 4 (2018)

Combined antihypertensive therapy in the light of modern recommendations: strategy of one tablet

Morozova T.

(Rus)

卷 15, 编号 4 (2018)

Modern combination antihypertensive pharmacotherapy

Mubarakshina O., Somova M., Batishcheva G.

(Rus)

Improving blood pressure control, organoprotection and metabolic disorders correction in patients with hypertension switching from diuretic-based combinations to fixed combination lisinopril + amlodipine + rosuvastatin

Nedogoda S., Chumachek E., Ledyaeva A., Tsoma V., Salasyuk A., Smirnova V., Khripaeva V., Palashkin R., Popova E.

(Rus)

卷 14, 编号 4 (2017)

Markers of early target-organ brain damage in essential arterial hypertension: the search continues. Possibilities of diffusion tensor magnetic resonance imaging

Parfenov V., Ostroumova T., Ostroumova O., Perepelova E., Perepelov V.

(Rus)

卷 13, 编号 4 (2016)

The effect of combined antihypertensive therapy on arterial wall rigidity in male patients with hypertension, obesity and obstructive sleep apnea

Elfimova E., Zairova A., Andrievskaya M., Bogieva R., Rogoza A., Litvin A.

(Rus)

«New» molecules composed of rational combinations of antihypertensive drugs: issues of choice

Kislyak O., Chervyakova Y.

(Rus)

卷 12, 编号 1 (2015)

Central and humoral mechanisms for arterial hypertension in women

Podzolkov V., Bragina A., Rodionova J., Koloda J.

(Rus)

卷 12, 编号 3 (2015)

Fixed dose combinations for the treatment arterial hypertension: the real way to improve control

Morozova T., Andreev S.

(Rus)

卷 11, 编号 4 (2014)

Once again about the clinical efficacy and safety of sartans

Minina Y., Khadzhieva B.

(Rus)

卷 11, 编号 4 (2014)

Methods of sympathetic activity evaluation in patients with systemic refractory hypertension

Grigin V., Danilov N., Sagaydak O., Shelkova G., Chazova I.

(Rus)

Clinico-pharmacological aspects of metoprolol use

Anikin G., Chernova I., Vinokurov V.

卷 10, 编号 2 (2013)

Sartans in the treatment of high-risk hypertension: the abilities of candesartan

Morozova T.

Analysis of associations between genetic markers of erythrocytes of ав0, Rh, mn, P, kell blood group systems and arterial hypertension at the Altai Republic population

Ogargov M., Mulerova T., Filimonov S., Luzina F., Onishchenko E.

Analysis of antihypertensive therapy and its adherence in hypertensive patients with and without concomitant diabetes mellitus

Sergeyeva V.

Obstructive sleep apnea syndrome

Litvin A., Chazova I.

卷 3, 编号 2 (2006)

Protivoishemicheskoe, antiaritmicheskoe i sosudistoe deystvie ingibitora angiotenzinprevrashchayushchego fermenta zofenoprila v eksperimente

Shlyakhto E., Galagudza M., Syrenskiy A., Blokhin I., Konstantinov I., Nifontov E.

Klinicheskaya i ekonomicheskaya effektivnost' lecheniya arterial'noy gipertenzii v usloviyakh statsionara: fokus na polnodozovye kombinatsii

Ostroumova O., Golovina O., Zhukova O., Sklyarova N., Bondarets O., Paukov S.

Kompleksnaya otsenka elasticheskikh svoystv i reaktivnosti intrakranial'nykh i perifericheskikh arteriy u patsientov s gipertonicheskoy bolezn'yu

Lebedev P., Maksimova L.

卷 17, 编号 4 (2020)

Contrast-associated acute kidney injury in patients with arterial hypertension and coronary artery disease and its long-term prognosis

Mironova O., Fomin V.

(Rus)

Performance of the Program of prevention and treatment of arterial hypertension in Ukraine (1999-2007)

Sirenko Y.

卷 6, 编号 4 (2009)

The use of angiotensin receptor blocker losartan in the combinational therapy of arterial hypertension

Zagidullin N., Zagidullin S.

Prevention of cardiovascular events at patients with arterial hypertension at treatmentangiotensin-converting enzyme inhibitor.

Kislyak O., Postnikova S.

卷 15, 编号 4 (2018)

Chronic myocardial damage in idiopathic pulmonary arterial hypertension: a clinical case

Bykov A., Arkhipov M., Klimusheva N., Iofin A., Krokhalev V.

(Rus)

Endothelin receptor antagonist bosentan role in modern strategy for patients with pulmonary arterial hypertension treatment

Arkhipova O., Martynyuk T.

(Rus)

卷 15, 编号 1 (2018)

Organoprotective properties of therapy by fixed combination of perindoprile and amlodipine in patients with arterial hypertension and diabetes mellitus type 2

Statsenko M., Turkina S., Titarenko M.

(Rus)

卷 14, 编号 3 (2017)

Calcineurin inhibitors and arterial hypertension in recipients of solid organs

Kosmacheva E., Martirosyan S., Lepshokova M., Babich A.

(Rus)

卷 13, 编号 3 (2016)

Combined pharmacotherapy of arterial hypertension. Overview fixed combination antihypertensive drugs

Morozova T., Andrushchishina T., Yudina I.

(Rus)

Clinical effects of one-year physical training program in arterial hypertension patients of working age who have suffered acute myocardial infarction (Russian randomized controlled trial)

Aronov D., Bubnova M., Krasnitskiy V., Ioseliani D., Grinshteyn Y., Gulyaeva S., Efremushkin G., Lyamina N.

(Rus)

Torasemid in the treatment of cardiovascular disease: the optimal use in conditions of comorbidity

Poteshkina N., Troshina A.

(Rus)

卷 12, 编号 1 (2015)

Radiofrequency renal arteries denervation: waiting for reply

Grigin V., Danilov N., Matchin Y., Shelkova G., Chazova I.

(Rus)

卷 12, 编号 2 (2015)

Efficacy and safety of different regimens of fixed combinationof perindopril 10 mg/indapamide 2.5 mg in patients with arterial hypertension

Elfimova E., Aksenova A., Litvin A., Chazova I.

(Rus)

Comparative evaluation of zofenopril. Are the characteristics of angiotensin I converting enzyme inhibitors important for the practice?

Kirichenko A.

(Rus)

Why occurrence of arterial hypertension with age becomes frequent?

Poseliugina O., Poseliugina E., Al-Galban N.

(Rus)

卷 11, 编号 1 (2014)

Place of angiotensin receptor blockers in antihypertensive therapy

Martynov A., Urlaeva I., Akatova E., Nikolin O.

(Rus)

Lercanidipine as a calcium antagonist of the third generation: a review of effectiveness in the hypertension treatment

Zadionchenko V., Shekhyan G., Yalymov A., Varentsov S.

卷 10, 编号 3 (2013)

Osobennosti techeniya serdechno-sosudistykh zabolevaniy i printsipy vybora ratsional'noy antigipertenzivnoy terapii u bol'nykh khronicheskoy obstruktivnoy bolezn'yu legkikh

Napalkov D., Panferov A.

Place of angiotensin receptor blockers in the treatment of hypertension according to the latest recommendations of the 2013 European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) for the treatment of hypertension

Chukaeva I., Solovieva M., Litvinova S.

Electrical and viscoelastic parameters of erythrocytes in patients with different degrees of arterial hypertension

Gromov A., Kruchinina M., Rabko A., Baum V., Generalov V.

B-ADRENOBLOCKERS IN THERAPY FOR ARTERIAL HYPERTENSION: ON THE WAY TO REASONABLE COMPROMISE

Perepech N., Shurygina V.

Perindopril in treatment of patients with arterial hypertension and high cardiovascular risk

Недогода С., Nedogoda S.

卷 3, 编号 2 (2006)

Effektivnost' i bezopasnost' tsilazaprila u patsientov s arterial'noy gipertoniey, perenesshikh insul't i/ili tranzitornuyu ishemicheskuyu ataku

Chazova I., Kolos I., Fedorova V., Pustovitova T., Ustyuzhanin D., Sinitsyn V., Starchina Y.

Sindrom obstruktivnogo apnoe vo vremya sna i arterial'naya gipertenziya

Chazova I., Litvin A.

卷 2, 编号 1 (2005)

Effektivnost' i bezopasnost' primeneniya Betaloka ZOK i Logimaksa u bol'nykh myagkoy arterial'noy gipertenziey v sochetanii s khronicheskoy obstruktivnoy bolezn'yu legkikh

Chazova I., Litvin A., Galitsin P., Ageeva N., Ratova L.

卷 16, 编号 1 (2019)

Obesity and hypertension: the role of criteria

Tsygankova D., Krivoshapova K., Maksimov S., Indukaeva E., Shapovalova E., Artamonova G., Barbarash O.

(Rus)

Atherosclerotic stenos of renal arteries at patients with diabetes mellitus and arterial hypertension.

Fomin V., Moiseev S., Shvetsov M., Mukhin N.

Arterial hypertension and treatment of non steroidal anti-inflammatory drugs: advantage amlodipin

Ezhov M., Yezhov M.

卷 14, 编号 3 (2017)

Interaction of antihypertensive drugs and rosuvastatin: focus on safety, efficiency and prospects

Luchinina E., Kompaniets O., Kizhvatova N.

(Rus)

卷 14, 编号 4 (2017)

Features of the use of torasemide in arterial hypertension

Baryshnikova G., Chorbinskajya S.

(Rus)

卷 14, 编号 1 (2017)

Arterial hypertension treatment changes in Yaroslavl region: results obtained after 4 years of complex program of regional healthcare system’s improvement implementation

Mozheyko M., Vigdorchik A., Eregin S., Danilenko N., Klimovskaya I., Ramanathan K., Hughes D.

(Rus)

卷 13, 编号 2 (2016)

Chronotherapy’s opportunities of a fixed combination of perindopril 10 mg/indapamide 2.5 mg in patients with a lack of night reduction in blood pressure

Aksenova A., Elfimova E., Litvin A., Chazova I.

(Rus)

Association of clinical and genetic factors with left ventricular hypertrophy in hypertension among the indigenous population Mountain Shoria

Mulerova T., Kuzmina A., Chigisova A., Voropaeva E., Maksimov V., Voevoda M., Ogarkov M.

(Rus)

卷 12, 编号 2 (2015)

The recommendations review concerning the maintenance of patients with arterial hypertension: evidence and expert opinions

Samorodskaya I., Boitsov S.

(Rus)

Possibilities ARB II (sartans) in hypertensive patients

Morozova T., Andrushchishina T., Gontarenko S.

(Rus)

卷 11, 编号 1 (2014)

Optimization of drug therapy of coronary heart disease and arterial hypertension: choice angiotensin-converting enzyme inhibitors

Trukhan D., Tarasova L.

(Rus)

卷 11, 编号 1 (2014)

Rational therapy of hypertension with concomitant ischemic heart disease

Chukaeva I., Orlova N., Soloveva M.

(Rus)

Riociguatas the first innovative guanylatecyclase stimulators class drugs for pulmonary arterial hypertension patients treatment

Chazova I., Martynyuk T.

Modern approaches to combined therapy of arterial hypertension

Napalkov D., Zhilenko A.

卷 10, 编号 2 (2013)

Additional possibilities of antihypertensive therapy for metabolic syndrome

Kislyak O., Pokhilchenko M.

卷 10, 编号 2 (2013)

Torasemide: additional benefits for postmenopausal women with arterial hypertension

Tkacheva O., Runikhina N., Sharashkina N.

卷 10, 编号 1 (2013)

Hypertension treatment: Is there a place for b-adrenoblockers?

Minushkina L.

The abilities of losartan in angioprotection in hypertensive patients with hyperuricemia

Nedogoda S., Ledyaeva A., Chumachok E., Tsoma V., Salasyuk A.

Amlodipin in the treatment of arterial hypertension

Galyavich A.

Lechenie patsienta s arterial'noy gipertenziey i gipertrofiey levogo zheludochka

Chazova I., Ratova L., Ataullakhanova D.

卷 1, 编号 2 (2004)

Kombinirovannaya terapiya arterial'noy gipertenzii s pozitsiy profilaktiki serdechno-sosudistykh oslozhneniy i patogeneza

Boytsov S.

卷 18, 编号 1 (2021)

Expert consensus. Effect of antihypertensive therapy on cognitive functions

Ostroumova O., Parfenov V., Ostroumova T., Yakhno N., Chazova I., Bogolepova A., Galyavich A., Geraskina L., Emelin A., Zakharov V., Kislyak O., Kulesh A., Levin O., Podzolkov V., Privalova E., Shikh E.

(Rus)

卷 16, 编号 4 (2019)

Radiofrequency denervation of the renal arteries in patients with resistant arterial hypertension: 3 years of observation experience

Savelyeva N., Zherzhova A., Mikova E., Gapon L., Kolunin G., Krinochkin D.

(Rus)

卷 16, 编号 4 (2019)

Role of fixed combinations in modern treatment of arterial hypertension: new or well overlooked old?

Adasheva T., Samorukova E., Zadionchenko V., Laricheva K.

(Rus)

卷 6, 编号 4 (2009)

Candesartan in the prevention of cardiovascular catastrophes: emphasis on the pre-vention of stroke

Drapkina O., Dikur O.

Renovaskulyarnaya arterial'naya gipertenziya: diagnostika i lechenie

Danilov N., Chazova I., Savchenko A.

Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients withtype 2 diabetes mellitus and mild hypertension:a sequential, randomized, double-blind clinical trial

Giuseppe Derosa -., Arrigo FG Cicero -., Angela D'Angelo -., Elena Fogari -., Sibilla Salvadeo -., Alessia Gravina -., Ilaria Ferrari -., Raffaella Fassi -., Roberto Fogari -.

Whether all ACE inhibitors enzyme are identical? Focus on zofenopril.

Ratova L., Chazova I.

Stroke prevention in patients with atrial fibrillation and comorbidities

Ostroumova O., Voevodina N., Guseva T., Pavleeva E., Piksina G., Goloborodova I.

(Rus)

卷 15, 编号 1 (2018)

Pulmonary hypertension: reasonable selection of specific therapy

Karoli N., Sazhnova S., Rebrov A.

(Rus)

卷 14, 编号 1 (2017)

Treatment of patients with high cardiovascular risk: a modern view on combined therapy

Blankova Z., Aslanian N., Smolianinova N., Ageev F.

(Rus)

卷 13, 编号 3 (2016)

Control of cardiovascular risk in patients with diabetes

Zhernakova Y., Chazova I.

(Rus)

卷 13, 编号 2 (2016)

Diuretics in combination antihypertensive therapy: focus on forecast

Chazova I., Martyniuk T.

(Rus)

卷 12, 编号 1 (2015)

Medical and social risk factors for arterial hypertension in coal miners

Indukaeva E., Makarov S., Ogarkov M.

(Rus)

卷 12, 编号 2 (2015)

Fibromuscular dysplasia as the cause of malignant renovascular hypertension in a newborn

Albot V., Dolgikh V., Gvak G., Pogodina A.

(Rus)

Nebivolol for treatment patients with arterial hypertension

Mikheeva O., Komisarenko I.

(Rus)

Effect of sildenafil on clinical evidence and hemodynamic parameters in patients with pulmonary arterial hypertension, associated withsystemic rheumaticdiseases

Volkov A., Udkina N., Kurmukov I., Nikolaeva Y., Nasonov Y.

(Rus)

The comparative analysis of therapy by «typical practice» and the fixed combination perindopril and indapamide an arterial hypertension with kidney insufficiency

Shiganov S., Baev V., Shulbayev A.

Iloprost for acute tests in patients with pulmonary arterial hypertension

Belyatko E., Danilov N., Matchin Y., Martynyuk T., Chazova I.

Diuretics in arterial hypertension: a focus on torasemide

Baryshnikova G., Stepanova I.

Efficacy of metoprolol in treatment and preventive of cardiovascular diseases

Chazova I., Ratova L., Ratova L., Chazova I.